首页 > 市场调查报告书 > 医疗设备

美容整形

市场调查报告书

商品编码

1535559

脸部注射剂市场规模- 分产品（胶原蛋白、PMMA微球、透明质酸、肉毒毒素、羟基磷灰石钙、聚左旋乳酸）、应用（除皱、脸部线条矫正、脸部提升）、最终用途和预测，2024年- 2032

Facial Injectables Market Size - By Product (Collagen, PMMA Microspheres, Hyaluronic Acid, Botulinum Toxin, Calcium Hydroxylapatite, Poly-L-lactic Acid), Application (Wrinkle Reduction, Facial Line Correction, Face Lift), End-use & Forecast, 2024 - 2032

出版日期: 2024年06月03日 | 出版商:

Global Market Insights Inc. | 英文 121 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在影像和注射技术不断进步的推动下，脸部注射剂市场规模预计从 2024 年到 2032 年复合年增长率将达到 10.3%。

许多公司正在致力于改进影像技术，以提供更精确和准确的脸部解剖学评估，从而提高注射剂的有效性和安全性。注射技术的创新也透过改进针头设计和注射方法的发展来最大限度地减少不适并最大化结果，以获得更好的结果。例如，2024 年 7 月，Juvederm 的 Juvederm Skinvive 获得美国 FDA 批准，这是其首款微滴面部注射剂，旨在提供更精緻、更自然的增强效果，以改善效果。

整个市场分为产品、应用、最终用途和区域。

就产品而言，由于对自然和持久增强的需求不断增加，到 2032 年，面部注射市场的脂肪注射设备细分市场将显着增长。最近，人们不断努力改进脂肪萃取、纯化和注射技术，以达到最佳效果。创新还改进了将脂肪顺利融入脸部组织的方法，以确保更好的轮廓和体积恢復。

从应用来看，由于消费者对增强唇部体积和轮廓的偏好不断增加，预计从 2024 年到 2032 年，丰唇领域的脸部注射剂产业份额将以显着的复合年增长率增长。技术进步正在改进用于此目的的注射剂，并改进配方以提供更自然和更持久的效果。注射技术的创新也有助于实现精确和对称的结果，同时最大限度地减少患者的不适和停工时间。

从地区来看，在名人的影响力、媒体曝光度的增加以及可支配收入的增加的推动下，亚太地区面部注射剂市场规模预计将在 2024 年至 2032 年间呈现利润丰厚的增长。该地区的媒体报导和名人代言正在推动脸部注射的兴趣和接受度，使其在流行文化中更加突出。产品供应和可及性的持续改进也将支持脸部注射剂的持续成长并将其融入主流美容和健康习惯中。

产业生态系统分析
产业影响力
- 成长动力
  - 老年人口不断增加
  - 脸部注射技术的进步
  - 提高对美容疗程的认识与接受度
- 产业陷阱与挑战
  - 严格的监管场景
  - 不良反应的风险
成长潜力分析
技术景观
监管环境
2023 年定价分析
- 按地区
- 按关键人物
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
胶原
聚甲基丙烯酸甲酯（PMMA）微球
透明质酸（HA）
肉毒桿菌毒素
羟基磷灰石钙 (CaHA)
聚左旋乳酸 (PLLA)
自体脂肪注射
其他产品

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
减少皱纹
脸部线条矫正
丰唇术
脸部提升
痤疮疤痕治疗
脂肪萎缩治疗
其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医疗水疗中心
皮肤科诊所
医院
其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

AbbVie Inc.
Anika Therapeutics, Inc.
APAX Partners
Bioplus Co., Ltd.
Croma-Pharma GmbH
Galderma SA
Ipsen Pharma
Lutronic Corporation
Medytox
Merz Pharma
Prollenium Medical Technologies
Revance Therapeutics, Inc.
Sinclair
Suneva Medical
Teoxane

简介目录

Product Code: 3909

Facial Injectables Market size is projected to record 10.3% CAGR from 2024 to 2032, driven by ongoing technological advancements in imaging and injection techniques.

Numerous companies are working on improving imaging technologies to provide more precise and accurate assessments of facial anatomy for enhancing the effectiveness and safety of injectables. Innovations in injection techniques are also minimizing discomfort and maximizing results with developments for refining needle designs and injection methods for better outcomes. For instance, in July 2024, Juvederm received the U.S. FDA approval for Juvederm Skinvive, its first micro droplet facial injectable designed to provide a more refined and natural-looking enhancement for improved results.

The overall market is segregated into product, application, end-use, and region.

In terms of product, the fat injection devices segment in the facial injectables market will experience significant growth by 2032, due to increasing demand for natural and long-lasting enhancements. Of late, there have been rising efforts on improving techniques for fat extraction, purification, and injection to achieve optimal results. Innovations are also refining the methods used in integrating the fat smoothly into facial tissues for ensuring better contouring and volume restoration.

By application, the facial injectables industry share from the lip augmentation segment is projected to grow at a notable CAGR from 2024 to 2032, driven by increasing consumer preference for enhanced lip volume and contour. Advancements are refining the injectables used for this purpose with improvements in formulations to provide more natural and longer-lasting results. Innovations in injection techniques are also helping in achieving precise and symmetrical outcomes while minimizing discomfort and downtime for patients.

Regionally, the Asia Pacific facial injectables market size is predicted to exhibit lucrative growth between 2024 and 2032, fueled by the influence of celebrities and increased media exposure, alongside rising disposable incomes. Media coverage and celebrity endorsements in the region are driving the interest and acceptance of facial injectables, making them more prominent in popular culture. The ongoing improvements in both product offerings and accessibility will also support the sustained growth and integration of facial injectables into mainstream beauty and wellness routines.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing geriatric population
  - 3.2.1.2 Technological advancements in facial injectables
  - 3.2.1.3 Increasing awareness and acceptance of aesthetic treatments
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory scenario
  - 3.2.2.2 Risk of adverse reactions
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Collagen
5.3 Poly methyl methacrylate (PMMA) microspheres
5.4 Hyaluronic acid (HA)
5.5 Botulinum toxin
5.6 Calcium hydroxylapatite (CaHA)
5.7 Poly-L-lactic acid (PLLA)
5.8 Fat injection
5.9 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Wrinkle reduction
6.3 Facial line correction
6.4 Lip augmentation
6.5 Face lift
6.6 Acne scar treatment
6.7 Lipoatrophy treatment
6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Medical spas
7.3 Dermatology clinics
7.4 Hospitals
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa